Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 6/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | HSD17B3 | P37058 | 5/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28846272 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL10618776 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL31740471 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL1960318 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL4186060 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL6518862 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL2916184 | 1.00 | DAGLA (0.48) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL972824 | 0.98 | DAGLA (0.46) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL7589893 | 0.93 | NPC1 (0.44) | DAGLAFAAHCES1TBXAS1HSD17B3 | |
| SCHEMBL10615856 | 0.93 | DAGLA (0.58) | DAGLAFAAHCES1FFAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797124-B1 | COVALENT GRAFTING OF HYDROPHOBIC SUBSTANCES ON COLLAGEN | BIOM UP (FR) | 2010-09-01 | — | — | EP | disclosed |
| US-20070260299-A1 | Covalent Grafting of Hydrophobic Substances on Collagen | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON (FR) | 2007-11-08 | — | — | US | disclosed |
| EP-1797124-A1 | COVALENT GRAFTING OF HYDROPHOBIC SUBSTANCES ON COLLAGEN | INSA (Institut National des Sciences Appliqées) (FR) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006037770-A1 | COVALENT GRAFTING OF HYDROPHOBIC SUBSTANCES ON COLLAGEN | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON (FR) | 2006-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070260299-A1 | Covalent Grafting of Hydrophobic Substances on Collagen | COL14A1, COL1A1, COL2A1 | DAGLA 2213/4885FAAH 2526/4885CES1 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.